NKF K/DOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of K/DOQI | Pediatric Bone| Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access

I. CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY

Tables

Table 1 Validated GFR-Estimating Equations
Table 2 Causes of Unusually Low or High Endogenous Creatinine Generation
Table 3 Causes of Unusually Low or High Kidney Tubular Creatinine Secretion
Table 4 Effect of Clearance on Patient Survival
Table 5 Effect of Fluid Removal on Clinical Outcomes
Table 6 Effect of Clearance on Technique Survival
Table 7 Potential Insults to RKF in Patients on Dialysis
Table 8 Effect of Pharmacological Interventions on RKF
Table 9 Various Domains to Be Considered for CQI Studies
Table 10 Complications That May Prompt Initiation of KRT
Table 11 Possible Indications to Consider Increasing the Dose of Dialysis

Table 12

 Possible Clinical Indications for Obtaining a 24-Hour RKF Collection
Table 13 Clinical Indications for Measurement of Peritoneal or Kidney Clearance
Table 14 Standardized Tests for Evaluating Peritoneal Membrane Transport/Function
Table 15 Clinical Indications for Repeat Peritoneal Membrane Transport Testing
Table 16 Mean Values of k
Table 17 Male Total Body Water (L) Nomograms
Table 18 Female Total Body Water (L) Nomograms
Table 19 Body Surface Area

© 2006 National Kidney Foundation, Inc.